Is Digital Health for Diabetes in an Investment Bubble?

bubble business diabetes digital health investment

Journal

Journal of diabetes science and technology
ISSN: 1932-2968
Titre abrégé: J Diabetes Sci Technol
Pays: United States
ID NLM: 101306166

Informations de publication

Date de publication:
01 2020
Historique:
pubmed: 1 9 2019
medline: 25 6 2021
entrez: 1 9 2019
Statut: ppublish

Résumé

An investment bubble occurs when there is a surge in asset prices that is not warranted by asset fundamentals because of irrationally exuberant market behavior. When prices rise to a level where no additional investors are willing to buy at the elevated price, then a massive sell-off typically occurs. Digital health investments represent approximately 10% of venture capital-backed startup investments, and diabetes digital health startups represent 4% of digital health investments. Attributes of a bubble indicate evidence for and against the current time period being in an investment bubble for digital health startups. After analyzing these attributes as well as the overall economy and the demand for healthcare products, we conclude that digital health startups and particularly digital health startups for diabetes are not in a bubble.

Identifiants

pubmed: 31470739
doi: 10.1177/1932296819867742
pmc: PMC7189152
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

165-169

Références

J Diabetes Sci Technol. 2019 Mar;13(2):159-163
pubmed: 30678473
Diabetes Metab. 2019 Dec;45(6):528-535
pubmed: 30677504
J Med Econ. 2019 Sep;22(9):869-877
pubmed: 31012392
Diabetes Technol Ther. 2019 Feb;21(2):66-72
pubmed: 30657336
J Diabetes Sci Technol. 2018 Sep;12(5):911-913
pubmed: 29719978
Br J Hosp Med (Lond). 2018 Jun 2;79(6):328-332
pubmed: 29894248

Auteurs

David C Klonoff (DC)

Mills-Peninsula Medical Center, San Mateo, CA, USA.

Bill Evans (B)

Rock Health, San Francisco, CA, USA.

Megan Zweig (M)

Rock Health, San Francisco, CA, USA.

Sean Day (S)

Rock Health, San Francisco, CA, USA.

David Kerr (D)

Sansum Diabetes Research Institute, Santa Barbara, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH